News
Novartis acquires Arctos Medical and its optogenetics based gene therapy programs.
Novartis has acquired Arctos Medical and its pre-clinical optogenetics based AAV gene therapy programs for treating inherited retinal dystrophies such as age related macular degeneration.
Type: industry